Schedule 13G ownership disclosure

SCPHARMACEUTICALS INC

Common Stock · CUSIP: 810648105

Event date: 2025-09-30

Filing-level shares
0.00
Percent of class
0%
  • LYTTON LAURENCE W

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-25-000685
Form type
SCHEDULE 13G/A
Filer
LYTTON LAURENCE W
CIK
CIK 1105806
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub